M. Thase
Clinical Psychology · 2000–2021
A researcher in the Science corpus: 28 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Clinical Psychology — 31 citations into it
- Cognitive Neuroscience — 20 citations into it; #7,349 of 10,852 by trust here, #3,702 by citations
Whom M. Thase trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Thase overall
- A. Beck
- Seth G. Disner
- Evi De Lissnyder
- M. Lumley
- Ernst H. W. Koster
- M. Kernis
- D. Dozois
- Brandon E. Gibb
- L. McGinn
- Kate L. Harkness
Papers from M. Thase's perspective
Ordered by how strongly the researchers M. Thase trusts endorse each paper. Same corpus, a different order for every researcher.
- For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion (NeuroImage)
- Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. (Neuroscience)
- Emotional Disorders and Metacognition: Innovative Cognitive Therapy
- Affective style, psychopathology, and resilience: brain mechanisms and plasticity. (American Psychologist)
- The PHQ-9 (Journal of general internal medicine)
- Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection (Annals of Internal Medicine)
- Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. (General Hospital Psychiatry)
- Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. (Biological Psychiatry)
- Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. (Biological Psychiatry)
- Measuring functional connectivity during distinct stages of a cognitive task (NeuroImage)
Their papers
- The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. (2003) — 3,653 citations
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (2021) — 613 citations
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. (2019) — 642 citations
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial (2017) — 638 citations
- You Gotta Work at It (2014) — 120 citations
- The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders (2013) — 664 citations
- Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders (2012) — 198 citations
- Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (2008) — 1,273 citations
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2008) — 98 citations
- Effectiveness of adjunctive antidepressant treatment for bipolar depression. (2007) — 850 citations
- Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. (2007) — 885 citations
- Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (2006) — 642 citations
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006) — 3,189 citations
- Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. (2006) — 2,735 citations
- Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. (2006) — 1,014 citations
- Medication augmentation after the failure of SSRIs for depression. (2006) — 990 citations
- Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006) — 673 citations
- Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. (2005) — 664 citations
- Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. (2004) — 1,030 citations
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (2003) — 810 citations